Navigation Links
IBF Conferences Inc., (International Business Forum) and BioEnterprise Present the 2nd Annual Global Healthcare Investing Conference
Date:2/19/2008

Leveraging Geography for a Competitive Advantage Uniting Venture Capitalists, Investment Bankers, International Start-Up CEOs, Business Development Executives, and Service Providers from Across

the Globe

MASSEPEQUA, N.Y. and CLEVELAND, Feb. 19 /PRNewswire/ -- IBF Conferences, Inc., the leading national investment conference organizer, and BioEnterprise, the Cleveland-based bioscience business formation, recruitment, and acceleration initiative, are proud to present the 2nd annual Global Healthcare Investing Conference. The conference brings together the leading-edge investors, institutions, and companies that invest in healthcare technologies across the world, manage "global" start-ups, and operate in multiple financial and regulatory markets.

The forum is geared specifically to US and international investors in and entrepreneurs of emerging bioscience companies. The event will be held April 29 - May 1, 2008 in Cleveland, Ohio, and is expected to once again draw over 70 investment firms and 300 attendees.

A world-renown Advisory Board guiding the conference agenda includes the following investors and firms:

Dean Banks Daniel Kosoy

Highland Capital Partners Athenian Venture Partners

Steve Burrill Carol Kovac

Burrill & Company Burrill & Company

Norman Chen Frank Kung

Fidelity Asia Ventures Ltd Vivo Ventures

Kent Gossett Vivian Lee

SR One Aqua Partners LLC

Avshalom Horan Ting Pau Oei

Bridge Investment Fund L.P L Capital

Andrew Jay Sanuj K. Ravindran, M.D.

Siemens Venture Capital, Inc Radius Ventures

Sanjay Sehgal

East West Capital Partners Pte. Ltd.

Baiju Shah Gerald Turner

BioEnterprise Corporation Seraphim Capital\ Focus Enterprises

Anthony Sun Anthony G. Viscogliosi

Aisling Capital Viscogliosi Bros., LLC

"We are excited to bring together the leading-edge practitioners to share ideas in this new area for health care investors," said IBF Conferences President & CEO Alexandra Scott. "Cleveland is the right location for this event given its prominence in health care investment with the region's many players already 'going global' to partner with start-ups. We are extremely pleased to partner with BioEnterprise to present this event given their success in working with global start-ups."

Scott cited the existence of many community initiatives in Cleveland that are focused on recruiting emerging technology companies from overseas. As an example, the BioEnterprise Initiative has already attracted nine venture-funded start-up companies from overseas locations such as Israel, Russia and Japan to the area.

"While other high-technology sectors attract global investment, global investing in healthcare ventures is still in its early stages," said BioEnterprise President Baiju R. Shah. "We are pleased to co-host this event with IBF given their leadership in organizing international investment gatherings."

The conference will also include a company showcase featuring 20 venture-backed healthcare companies from outside the U.S. that are looking for Series B or later investment rounds.

About BioEnterprise

BioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to health care companies. BioEnterprise's partners are Case Western Reserve University, the Cleveland Clinic, University Hospitals, and Summa Health System. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech and BioOhio.

The initiative comprises the collaborative activities of BioEnterprise and its partners' commercialization offices: the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research, and Summa Enterprise Group. The combined efforts of these groups has created, recruited, and accelerated more than 60 companies in four years.

About IBF Conferences

IBF - International Business Forum presents financial and business conferences on venture capital, corporate finance, mergers & acquisitions, corporate strategic investing, investment management, risk management, funding technology innovation, commercialization of intellectual property and corporate employee benefits. IBF conferences provide attendees with leading-edge information, and new business contacts to achieve business objectives. Founded in 1989 by Alexandra Scott, International Business Forum organizes conferences to provide strategic information and key business contacts. Attendees include: venture capitalists, investment and commercial bankers, chief executive officers, chief financial officers, pension, endowment and foundation investment officers, corporate investors, money managers, new business development executives and corporate decision makers.


'/>"/>
SOURCE IBF Conferences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
2. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
3. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
4. Thermo Fisher Scientific to Present at Investor Conferences
5. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
6. Suntech to Attend Upcoming Investor Conferences and Industry Events
7. American Oriental Bioengineering Announces Participation in September Investor Conferences
8. Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
9. Vical to Present at Upcoming Investor Conferences
10. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
11. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Eurofins announces the appointment of Sean Murray , National Division ... Mr. Murray will bring valuable expertise to the ... leading international business teams. As the National Division Leader, he will ... status as the global leader in bio-analytical testing services. ... , , ...
(Date:12/8/2016)... Dec. 8, 2016  Anaconda BioMed S.L., a pre-clinical ... the next generation neuro-thrombectomy system for the treatment of ... G. Jovin, MD to join its Scientific Advisory Board ... strategic network of scientific and clinical experts to Anaconda ... the ANCD BRAIN ® to its clinical phase. ...
(Date:12/8/2016)... 8, 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... on developing and commercializing products to treat rare ... announced today the long-term follow-up data from its ... first-in-class Innate Defense Regulator (IDR), in the treatment ... cancer patients undergoing chemoradiation therapy (CRT).  The additional ...
(Date:12/8/2016)... -- Partnering to fuel Philadelphia,s innovative ... Southeastern Pennsylvania (" Ben Franklin "); ... Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... million funding initiative over a four year period to ... a burgeoning economic vitality in digital health, Ben ...
Breaking Biology Technology:
(Date:12/8/2016)... Calif. , Dec. 8, 2016  Singulex, Inc., ... Molecule Counting technology, entered into a license and supply ... serving science. The agreement provides Singulex access to Thermo ... Europe is used to diagnose systemic ... United States to aid in assessing the ...
(Date:12/7/2016)...   Veridium , a leader in biometrics-based ... CEO James Stickland . Stickland, a seasoned ... has served in senior executive roles for HSBC, ... expanding a pipeline of venture capital and accelerating ... served as managing director of U.K.-based fintech firm ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office of ... published "Can CT Scans Enhance or Replace Medico ... potential of supporting or replacing forensic autopsies with ... scan. In response to recommendations made ... exploring using CT scans as a potential component ...
Breaking Biology News(10 mins):